Search research articles
Contact Us
Filters
Showing results (71-80 of 76) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 76 results.
Leukemia
|
September 12, 2008
Apolipoprotein E genotype as a determinant of survival in chronic lymphocytic leukemia
J B Weinberg, A D Volkheimer, M Mihovilovic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1997
Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461
J C Byrd, R B Weiss, D C Arthur, et al.
Blood
|
May 23, 2001
High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361)
M R Baer, C C Stewart, R K Dodge, et al.
Annals of Hematology
|
May 6, 2004
Core binding factor acute myeloid leukemia. Cancer and Leukemia Group B (CALGB) Study 8461
C D Bloomfield, A S Ruppert, K Mrózek, et al.
Leukemia
|
June 21, 2012
Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function
D J DiLillo, J B Weinberg, A Yoshizaki, et al.
Leukemia
|
September 11, 2014
Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemia
C Niederwieser, J Kohlschmidt, S Volinia, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 76) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 76 results.
Leukemia
|
September 12, 2008
Apolipoprotein E genotype as a determinant of survival in chronic lymphocytic leukemia
J B Weinberg, A D Volkheimer, M Mihovilovic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1997
Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461
J C Byrd, R B Weiss, D C Arthur, et al.
Blood
|
May 23, 2001
High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361)
M R Baer, C C Stewart, R K Dodge, et al.
Annals of Hematology
|
May 6, 2004
Core binding factor acute myeloid leukemia. Cancer and Leukemia Group B (CALGB) Study 8461
C D Bloomfield, A S Ruppert, K Mrózek, et al.
Leukemia
|
June 21, 2012
Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function
D J DiLillo, J B Weinberg, A Yoshizaki, et al.
Leukemia
|
September 11, 2014
Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemia
C Niederwieser, J Kohlschmidt, S Volinia, et al.
Page
of 8